Advent Life Sciences Fund III LP
Advent Life Sciences · adviser of record: Advent Life Sciences LLP · 2018 vintage
Advent Life Sciences Fund III LP is a 2018 venture fund managed by Advent Life Sciences, with $24.8mm raised (Form D, amount sold). It reported $154mm in gross assets at year-end 2025, 6.21x its size, against a peak of $154mm in 2021.
- Latest value held
- $154mm year-end 2025
- Peak
- $154mm year-end 2021
- Fund size
- $24.8mm Form D, amount sold
- Held vs. size
- 6.21x peak 6.22x
Value held by year-end
Gross asset value reported on Form ADV at each year-end. Dashed line: fund size. Open in the Fund Tracker
| Year-end | Gross assets | ÷ size | Change |
|---|---|---|---|
| 2025 | $154mm | 6.21x | +5% over 2 yrs |
| 2023 | $147mm | 5.94x | +0% |
| 2022 | $147mm | 5.92x | -5% |
| 2021 | $154mm | 6.22x | +0% |
| 2020 | $154mm | 6.20x | +11% |
| 2019 | $138mm | 5.56x | -2% |
| 2018 | $140mm | 5.66x | – |
Other funds from Advent Life Sciences
- Advent-Harrington Impact Fund LP 2020
- Advent Life Sciences II CO-Invest LP 2019
- Advent Life Sciences Fund I LP 2014
- Advent Life Sciences Fund II LP 2014
- Biomotiv LLC 2012
All Advent Life Sciences funds
About these numbers
Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-2883803215. Data updated October 13, 2026.
Is this your fund?
Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.